Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million

Reuters11-13

Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million

Nuwellis Inc. reported third quarter 2025 revenue of $2.2 million, compared to $2.4 million in the same quarter last year. On a pro-forma basis, revenue increased approximately 7% year-over-year, excluding one-time SeaStar medical revenue and decreased international revenue due to wind-down activities. Gross margin was 65.2%, down from 70.0% in the prior year period. Operating expenses rose 30% year-over-year to $4.1 million, reflecting increased investment in rebuilding the U.S. sales force and additional spending on engineering and quality systems. The company reported an operating loss of $2.7 million, compared to $1.5 million last year, and ended the quarter with $3.1 million in cash and cash equivalents, remaining debt-free. Key business developments included the transition of manufacturing to KDI Precision Manufacturing, exit from international operations to focus on the U.S. market, and raising $1.9 million through an ATM facility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-041591), on November 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583050583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 00:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583050583","market":"us","top_or_hot":-1,"title":"Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Nuwellis Inc. reported third quarter 2025 revenue of $2.2 million, compared to $2.4 million in the same quarter last year. On a pro-forma basis, revenue increased approximately 7% year-over-year, excluding one-time SeaStar medical revenue and decreased international revenue due to wind-down activities. Gross margin was 65.2%, down from 70.0% in the prior year period. Operating expenses rose 30% year-over-year to $4.1 million, reflecting increased investment in rebuilding the U.S. sales force and additional spending on engineering and quality systems. The company reported an operating loss of $2.7 million, compared to $1.5 million last year, and ended the quarter with $3.1 million in cash and cash equivalents, remaining debt-free. Key business developments included the transition of manufacturing to KDI Precision Manufacturing, exit from international operations to focus on the U.S. market, and raising $1.9 million through an ATM facility.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-041591), on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-13 00:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Nuwellis Inc. reported third quarter 2025 revenue of $2.2 million, compared to $2.4 million in the same quarter last year. On a pro-forma basis, revenue increased approximately 7% year-over-year, excluding one-time SeaStar medical revenue and decreased international revenue due to wind-down activities. Gross margin was 65.2%, down from 70.0% in the prior year period. Operating expenses rose 30% year-over-year to $4.1 million, reflecting increased investment in rebuilding the U.S. sales force and additional spending on engineering and quality systems. The company reported an operating loss of $2.7 million, compared to $1.5 million last year, and ended the quarter with $3.1 million in cash and cash equivalents, remaining debt-free. Key business developments included the transition of manufacturing to KDI Precision Manufacturing, exit from international operations to focus on the U.S. market, and raising $1.9 million through an ATM facility.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-041591), on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NUWE","symbol_name":"Nuwellis, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2xHJlq:1","article_id":"2583050583","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583050583","pubTimestamp":1762966225,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Nuwellis Inc. reported third quarter 2025 revenue of $2.2 million, compared to $2.4 million in the same quarter last year. On a pro-forma basis, revenue increased approximately 7% year-over-year, excluding one-time SeaStar medical revenue and decreased international revenue due to wind-down activities. Gross margin was 65.2%, down from 70.0% in the prior year period. Operating expenses rose 30% year-over-year to $4.1 million, reflecting increased investment in rebuilding the U.S. sales force and additional spending on engineering and quality systems. The company reported an operating loss of $2.7 million, compared to $1.5 million last year, and ended the quarter with $3.1 million in cash and cash equivalents, remaining debt-free. Key business developments included the transition of manufacturing to KDI Precision Manufacturing, exit from international operations to focus on the U.S. market, and raising $1.9 million through an ATM facility.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NUWE":"Nuwellis, Inc.","BK4082":"医疗保健设备","ICU":"SeaStar Medical Holding Corporation"},"translate_title":"Nuwellis报告第三季度收入为220万美元，运营亏损为270万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUWE":0.9,"ICU":0.9},"content_text":"Nuwellis reports Q3 revenue of $2.2 million and operating loss of $2.7 million\n    \n\n        Nuwellis Inc. reported third quarter 2025 revenue of $2.2 million, compared to $2.4 million in the same quarter last year. On a pro-forma basis, revenue increased approximately 7% year-over-year, excluding one-time SeaStar medical revenue and decreased international revenue due to wind-down activities. Gross margin was 65.2%, down from 70.0% in the prior year period. Operating expenses rose 30% year-over-year to $4.1 million, reflecting increased investment in rebuilding the U.S. sales force and additional spending on engineering and quality systems. The company reported an operating loss of $2.7 million, compared to $1.5 million last year, and ended the quarter with $3.1 million in cash and cash equivalents, remaining debt-free. Key business developments included the transition of manufacturing to KDI Precision Manufacturing, exit from international operations to focus on the U.S. market, and raising $1.9 million through an ATM facility.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-041591), on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583050583","isCrawlerRequest":true}